Citation

Erdemir F, Harbin A, Hellstrom WJG. J. Sex. Med. 2008; 5(12): 2917-2924.

Copyright

(Copyright © 2008, International Society for Sexual Medicine, Publisher John Wiley and Sons)

DOI

10.1111/j.1743-6109.2008.01001.x

PMID

unavailable

Abstract

Introduction.  Benign prostatic hyperplasia (BPH) is a common problem affecting middle-aged and elderly men. First-line medical therapy includes α 1blockers and 5α-reductase inhibitors (5ARIs), such as finasteride and dutasteride. 5ARI use has been associated with adverse sexual outcomes, including erectile dysfunction (ED), ejaculatory dysfunction (EjD), and decreased libido.